Surgical outcomes in steroid refractory acute severe ulcerative colitis: The impact of rescue therapy

Colorectal Disease

Volumn 15, Issue 3, 2013, Pages 374-379

  Powar, M P ^a   Martin, P ^a   Croft, A R ^a   Walsh, A ^b   Petersen, D ^a   Stevenson, A R L ^a   Lumley, J W ^c   Stitz, R W ^a   Radford Smith, G L ^a,d   Clark, D A ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c WESLEY HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute colitis; Colectomy; Complications; Rescue therapy

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; HYDROCORTISONE; INFLIXIMAB;

ADULT; AGED; ARTICLE; CHEST INFECTION; COLON RESECTION; CONTROLLED STUDY; DRUG MEGADOSE; DUODENUM ULCER; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SINGLE DRUG DOSE; STEROID REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS; SURGICAL MORTALITY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874358111     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03188.x     Document Type: Article

References (17)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955; 24947: 1041-8.
2. Dinesen LC, Walsh AJ, Protic MN et al. The pattern and outcome of acute severe colitis. J Crohns Colitis 2010; 4: 431-7.
3. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963; 4: 299-315.
4. Turner D, Walsh CM, Steinhart AH et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007; 51: 103-10.
5. Randall J, Singh B, Warren BF et al. Delayed surgery for acute severe colitis is associated with increased risk of post-operative complications. Br J Surg 2010; 97: 404-9.
6. Milsom JW, Hammerhofer KA, Bohm B, Marcello P, Elson P, Fazio VW. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease. Dis Colon Rectum 2001; 44: 1-8.
7. Holubar SD, Larson DW, Dozois EJ, Pattana-Arun J, Pemberton JH, Cima RR. Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach?Dis Colon Rectum 2009; 52: 187-92.
8. Chung TP, Fleshman JW, Birnbaum EH et al. Laparoscopic vs. open total abdominal colectomy for severe colitis: impact on recovery and subsequent completion restorative proctectomy. Dis Colon Rectum 2009; 52: 4-10.
9. Telem DA, Vine AJ, Swain G et al. Laparoscopic subtotal colectomy for medically refractory ulcerative colitis: the time has come. Surg Endosc 2010; 24: 1616-20.
10. Dowson HM, Bong JJ, Lovell DP, Worthington TR, Karanjia ND, Rockall TA. Reduced adhesion formation following laparoscopic versus open colorectal surgery. Br J Surg 2008; 95: 909-14.
11. Mor IJ, Vogel JD, da Luz Moreira A, Shen B, Hammel J, Remzi FH. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008; 51: 1202-7; discussion, 1207-10.
12. Selvasekar CR, Cima RR, Larson DW et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204: 956-62; discussion, 962-3.
13. Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bor-deianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 2008; 12: 1730-6.
14. Schluender SJ, Ippoliti A, Dubinsky M et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis. Dis Colon Rectum 2007; 50: 1747-53.
15. Ferrante M, D'Hoore A, Vermeire S et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1062-70.
16. Schmidt M, Luegering N, Luegering A. Infliximab exerts antiinflammatory capacity in IBD by induction of apoptosis in monocytes. Gastroenterology 2000; 118: 3630.
17. Lee L, Efron D, Tantry U. Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats. Wound Repair Regen 2000; 8: 547-53.